CRO to invest $100 million in Celtic Therapeutics Holdings

Pharmaceutical Product Development Inc, a contract research organisation based in Wilmington, North Carolina, is to invest $100 million in Celtic Therapeutics Holdings LP, itself an investor in mid-stage drug candidates.